Clinical Trials
4 trialsNCT05333250 2026-01-13
MODIFY
Ottawa Hospital Research Institute
Phase 1/2 Recruiting
NCT01330446 2024-02-14
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT01048983 2015-03-05
Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT01219673 2015-02-10
Symptom Burden in Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1/2 Terminated